跳至主要内容
临床试验/ACTRN12618000577213
ACTRN12618000577213招募中1 期

Chitosan-dextran (Chitodex) gel with and without Deferiprone and Gallium-Protoporphyrin-wound healing and post operative outcomes in the treatment of Chronic Rhinosinusitis (CRS)

The University of Adelaide0 个研究点目标入组 90 人开始时间: 2018年4月16日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants who meet ALL of the following criteria will be offered inclusion in the study:
  • Those who have had symptoms of chronic rhinosinusitis (nasal discharge, postnasal drip, nasal obstruction, facial pain and pressure, lack of sense of smell) that has been previously persistent for greater than 3 months AND
  • are over 18 years of age AND
  • are able to give written informed consent AND
  • are local and who will be returning to this centre for postoperative follow-up care AND
  • are indicated to undergo endoscopic sinus surgery and willing to return at 2, 6 & 12 weeks post-op.

排除标准

  • 1. allergy to shellfish
  • 2. pregnant or breastfeeding
  • 3. Hepatitis or blood disorders.
  • 4.any drug allergy

研究者

相似试验

Effect of novel drug with Chitodex gel on wound... | 临床试验